These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 11562290)
1. The role of genomics in antibacterial target discovery. Buysse JM Curr Med Chem; 2001 Dec; 8(14):1713-26. PubMed ID: 11562290 [TBL] [Abstract][Full Text] [Related]
2. Rational identification of new antibacterial drug targets that are essential for viability using a genomics-based approach. Chalker AF; Lunsford RD Pharmacol Ther; 2002 Jul; 95(1):1-20. PubMed ID: 12163125 [TBL] [Abstract][Full Text] [Related]
3. Genomics and the prospects for the discovery of new targets for antibacterial and antifungal agents. Isaacson RE Curr Pharm Des; 2002; 8(13):1091-8. PubMed ID: 12052221 [TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive essential gene identification as a platform for novel anti-infective drug discovery. Haselbeck R; Wall D; Jiang B; Ketela T; Zyskind J; Bussey H; Foulkes JG; Roemer T Curr Pharm Des; 2002; 8(13):1155-72. PubMed ID: 12052225 [TBL] [Abstract][Full Text] [Related]
6. The impact of genomics on novel antibacterial targets. Payne DJ; Wallis NG; Gentry DR; Rosenberg M Curr Opin Drug Discov Devel; 2000 Mar; 3(2):177-90. PubMed ID: 19649849 [TBL] [Abstract][Full Text] [Related]
7. Novel approaches to the discovery of antimicrobial agents. Schmid MB Curr Opin Chem Biol; 1998 Aug; 2(4):529-34. PubMed ID: 9736927 [TBL] [Abstract][Full Text] [Related]
8. New antibiotic discovery, novel screens, novel targets and impact of microbial genomics. Allsop AE Curr Opin Microbiol; 1998 Oct; 1(5):530-4. PubMed ID: 10066524 [TBL] [Abstract][Full Text] [Related]
9. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Tomioka H Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755 [TBL] [Abstract][Full Text] [Related]
10. The role of genomics in the discovery of novel targets for antibiotic therapy. Ji Y Pharmacogenomics; 2002 May; 3(3):315-23. PubMed ID: 12052140 [TBL] [Abstract][Full Text] [Related]
11. Streptococcus pneumoniae as a genomics platform for broad-spectrum antibiotic discovery. Glass JI; Belanger AE; Robertson GT Curr Opin Microbiol; 2002 Jun; 5(3):338-42. PubMed ID: 12057692 [TBL] [Abstract][Full Text] [Related]
12. T-iDT : tool for identification of drug target in bacteria and validation by Mycobacterium tuberculosis. Singh NK; Selvam SM; Chakravarthy P In Silico Biol; 2006; 6(6):485-93. PubMed ID: 17518759 [TBL] [Abstract][Full Text] [Related]
13. Novel antibacterials: a genomics approach to drug discovery. Chan PF; Macarron R; Payne DJ; Zalacain M; Holmes DJ Curr Drug Targets Infect Disord; 2002 Dec; 2(4):291-308. PubMed ID: 12570737 [TBL] [Abstract][Full Text] [Related]
14. Functional genomics in antibacterial drug discovery. Freiberg C; Brötz-Oesterhelt H Drug Discov Today; 2005 Jul; 10(13):927-35. PubMed ID: 15993812 [TBL] [Abstract][Full Text] [Related]
15. Genomics in anti-infective drug discovery--getting to endgame. Haney SA; Alksne LE; Dunman PM; Murphy E; Projan SJ Curr Pharm Des; 2002; 8(13):1099-118. PubMed ID: 12052222 [TBL] [Abstract][Full Text] [Related]
17. When will the genomics investment pay off for antibacterial discovery? Mills SD Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281 [TBL] [Abstract][Full Text] [Related]
18. Using genomics to develop novel antibacterial therapeutics. Nagaraj NS; Singh OV Crit Rev Microbiol; 2010 Nov; 36(4):340-8. PubMed ID: 20670176 [TBL] [Abstract][Full Text] [Related]